Topchoice Medical (600763.SS) Earnings Analysis

Topchoice Medical (600763.SS) next reports earnings on 2026-08-15, consensus EPS 0.3132 CNY. Last quarter (2026-04-17) it missed with EPS -0.02583 CNY vs 0.02 CNY est (-229.1%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 31.37.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 600763.SS next report earnings?

Next earnings date2026-08-15
Consensus EPS estimate0.3132 CNY
Revenue estimate0.77B

600763.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-17-0.02583 CNY0.02 CNY-229.1%Miss
2025-10-270.43 CNY0.4256 CNY+1%Beat
2025-08-220.3084 CNY0.31 CNY-0.5%Miss
2025-04-250.01 CNY0.09 CNY-88.9%Miss
2024-10-280.42 CNY0.5 CNY-16%Miss
2024-08-230.58 CNY0.31 CNY+87.1%Beat

Beat rate: 2/6 (33%) over reported quarters with consensus data.

600763.SS valuation and analyst view

Trailing P/E31.37
Trailing EPS1.129 CNY
Price / book3.60
Dividend yield0.00%
Market cap15.99B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Topchoice Medical (600763.SS)'s next earnings date?

Topchoice Medical is next scheduled to report on 2026-08-15, with a consensus EPS estimate of 0.3132 CNY and revenue estimate of 0.77B.

Did 600763.SS beat earnings last quarter?

In its 2026-04-17 report, 600763.SS posted EPS of -0.02583 CNY versus a 0.02 CNY estimate — a miss of 229.1%.

What is 600763.SS's earnings track record?

Over the last 6 reported quarters with consensus data, 600763.SS beat estimates 2 times (33%).

What is 600763.SS's current P/E ratio and EPS?

600763.SS trades at a trailing P/E of 31.37 on trailing EPS of 1.1287898068845703 CNY.

What do analysts rate 600763.SS?

600763.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.